73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
The power of machine learning in prostate cancer imaging

The power of machine learning in prostate cancer imaging

by Lisette Hilton,University of Miami(From left) Isaac R. L. Xu; Derek J. Van Booven; and Himanshu Arora, Ph.D. Credit: University of MiamiResearchers at Sylvester Comprehensive Cancer Center an

The power of machine learning in prostate cancer imaging

by Lisette Hilton,University of Miami(From left) Isaac R. L. Xu; Derek J. Van Booven; and Himanshu Arora, Ph.D. Credit: University of MiamiResearchers at Sylvester Comprehensive Cancer Center an
Thalidomide reveals path for targeting undruggable transcription factors for cancer treatment

Thalidomide reveals path for targeting undruggable transcription factors for cancer treatment

by Tom Ulrich,Broad Institute of MIT and HarvardCredit: Susanna M. Hamilton, Broad CommunicationsThalidomide, a morning-sickness drug recalled in the 1960s because it caused devastating birth de

Thalidomide reveals path for targeting undruggable transcription factors for cancer treatment

by Tom Ulrich,Broad Institute of MIT and HarvardCredit: Susanna M. Hamilton, Broad CommunicationsThalidomide, a morning-sickness drug recalled in the 1960s because it caused devastating birth de
New biotechnology combines targeted and immune therapies to kill treatment-resistant cancer cells

New biotechnology combines targeted and immune therapies to kill treatment-resistant cancer cells

byNYU Langone HealthBinding profiles soto-p7/A03 (top row) and p7WT/A03 (bottom row) of clone R011 (left column), the naïve deep mutational scanning library (middle column), and the pool after s

New biotechnology combines targeted and immune therapies to kill treatment-resistant cancer cells

byNYU Langone HealthBinding profiles soto-p7/A03 (top row) and p7WT/A03 (bottom row) of clone R011 (left column), the naïve deep mutational scanning library (middle column), and the pool after s
Research: Insufficient evidence to recommend low-dose CT screening in never smokers

Research: Insufficient evidence to recommend low-dose CT screening in never smokers

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainLung cancer remains the leading cause of cancer-related deaths worldwide. Detecting this disease in its early

Research: Insufficient evidence to recommend low-dose CT screening in never smokers

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainLung cancer remains the leading cause of cancer-related deaths worldwide. Detecting this disease in its early
Researchers confirm links between aggressive prostate cancer and hereditary breast cancer

Researchers confirm links between aggressive prostate cancer and hereditary breast cancer

by The Spanish National Cancer Research CentreDavid Olmos and Elena Castro, from the CNIO Prostate Cancer Clinical Research Unit. Credit: CNIOAggressive prostate cancer, one of the leading causes

Researchers confirm links between aggressive prostate cancer and hereditary breast cancer

by The Spanish National Cancer Research CentreDavid Olmos and Elena Castro, from the CNIO Prostate Cancer Clinical Research Unit. Credit: CNIOAggressive prostate cancer, one of the leading causes
Phase 1 study shows novel KRAS inhibitor well tolerated by patients with adenocarcinoma and non-small cell lung cancer

Phase 1 study shows novel KRAS inhibitor well tolerated by patients with adenocarcinoma and non-small cell lung cancer

by International Association for the Study of Lung CancerLung CA seen on CXR. Credit:CC BY-SA 4.0James Heilman, MD/WikipediaA clinical trial testing the toxicity of a KRAS inhibitor demons

Phase 1 study shows novel KRAS inhibitor well tolerated by patients with adenocarcinoma and non-small cell lung cancer

by International Association for the Study of Lung CancerLung CA seen on CXR. Credit:CC BY-SA 4.0James Heilman, MD/WikipediaA clinical trial testing the toxicity of a KRAS inhibitor demons
Trial shows promise for new antibody cancer treatment

Trial shows promise for new antibody cancer treatment

byKing's College LondonMechanism of cytotoxicity mediated by MOv18 IgE. Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-39679-9The first ever clinical trial of a new

Trial shows promise for new antibody cancer treatment

byKing's College LondonMechanism of cytotoxicity mediated by MOv18 IgE. Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-39679-9The first ever clinical trial of a new
Dangerous skin tumor now has treatment guidelines

Dangerous skin tumor now has treatment guidelines

by Northwestern UniversityCredit: CC0 Public DomainIt starts as a yellow or shiny bump on the eyelids, face or body that grows and doesn't go away, unlike a pimple.The bump is sebaceous carci

Dangerous skin tumor now has treatment guidelines

by Northwestern UniversityCredit: CC0 Public DomainIt starts as a yellow or shiny bump on the eyelids, face or body that grows and doesn't go away, unlike a pimple.The bump is sebaceous carci
Pilot program explores use of essential oils to manage side effects, promote comfort during cancer treatment

Pilot program explores use of essential oils to manage side effects, promote comfort during cancer treatment

by Donna Fisher,Rush University Medical CenterCredit: CC0 Public DomainWhat do sweet orange, lavender, peppermint and spearmint have in common? They all smell good, and now a study at Rush Cople

Pilot program explores use of essential oils to manage side effects, promote comfort during cancer treatment

by Donna Fisher,Rush University Medical CenterCredit: CC0 Public DomainWhat do sweet orange, lavender, peppermint and spearmint have in common? They all smell good, and now a study at Rush Cople
Avelumab plus axitinib significantly improve progression-free survival in untreated renal cell carcinoma

Avelumab plus axitinib significantly improve progression-free survival in untreated renal cell carcinoma

byEuropean Society for Medical OncologyCredit: CC0 Public DomainA combination of the immune checkpoint blocker, avelumab, plus the tyrosine kinase inhibitor (TKI), axitinib, significantly improv

Avelumab plus axitinib significantly improve progression-free survival in untreated renal cell carcinoma

byEuropean Society for Medical OncologyCredit: CC0 Public DomainA combination of the immune checkpoint blocker, avelumab, plus the tyrosine kinase inhibitor (TKI), axitinib, significantly improv
Researchers develop gel to deliver cancer drugs for solid tumors

Researchers develop gel to deliver cancer drugs for solid tumors

byMass General BrighamCredit: Pixabay/CC0 Public DomainIntratumoral therapy—in which cancer drugs are injected directly into tumors—is a promising treatment option for solid cancers but has show

Researchers develop gel to deliver cancer drugs for solid tumors

byMass General BrighamCredit: Pixabay/CC0 Public DomainIntratumoral therapy—in which cancer drugs are injected directly into tumors—is a promising treatment option for solid cancers but has show
Researchers discover the role of RNF114B, a key gene in the progression and treatment of lung adenocarcinoma

Researchers discover the role of RNF114B, a key gene in the progression and treatment of lung adenocarcinoma

byUniversitat Pompeu Fabra - BarcelonaA mouse fibroblast with altered RNF144B expression divides without correctly grouping chromosomes (stained blue), resulting in aberrant cells. Credit: UPFRe

Researchers discover the role of RNF114B, a key gene in the progression and treatment of lung adenocarcinoma

byUniversitat Pompeu Fabra - BarcelonaA mouse fibroblast with altered RNF144B expression divides without correctly grouping chromosomes (stained blue), resulting in aberrant cells. Credit: UPFRe